In breast cancer, TIMP2 immunoexpression may be localized in cancer as well as stromal cells, however mRNA in situ hybridization indicates a lower TIMP2 synthesis in stromal cells than in tumour cells [42]. This evidence concerns the gene TIMP2 and breast carcinoma.